AnGes granted Nippon Zoki exclusive, Japanese development and commercialization rights to NF-kappa B decoy to treat lower back pain and disk degeneration

AnGes MG Inc.

Japan / Small-Cap Biopharma (<$1 billion)

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Nippon Zoki Pharmaceutical Co. Ltd.

Japan / Private Biopharma

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced